Skip to main content
Clinical Trials/DRKS00029665
DRKS00029665
Not yet recruiting
Not Applicable

OBJECTIVE, CLINICIAN- AND PATIENT-REPORTED EVALUATION OF LATE TOXICITY FOLLOWING ADJUVANT RADIATION IN EARLY BREAST CANCER: FOLLOW-UP RESULTS OF A RANDOMISED SERIES - FibroLate

Klinik für Strahlentherapie und Radioonkologie; Universitätsklinikum Bonn0 sites100 target enrollmentJuly 19, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C50
Sponsor
Klinik für Strahlentherapie und Radioonkologie; Universitätsklinikum Bonn
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Strahlentherapie und Radioonkologie; Universitätsklinikum Bonn

Eligibility Criteria

Inclusion Criteria

  • breast\-conserving surgery for breast cancer
  • \- completion of a normofractionated or moderately hypofractionated radiation course without interruptions
  • \- written informed consent

Exclusion Criteria

  • \- double\-sided breast cancer (since the contralateral breast is used as an intrapatient control)
  • \- mastectomy
  • \- breast reconstruction with implant
  • \- history of recurrent disease with ipsilateral re\-lumpectomy or re\-irradiation
  • \- metastatic disease
  • \- any preexisting dermatological disorders
  • \- active dermatitis
  • \- current treatment with topical or oral corticosteroids
  • \- patient refusal to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials